NANOFH — Nanoform Finland Oyj Share News
0.000.00%
Last trade - 00:00- €63.63m
- €51.03m
- €3.55m
Brief: Nanoform Finland Q4 EBITDA Loss Widens To EUR 4.8 Million
Brief: Nanoform Signs GMP Manufacturing Program With Targtex
Brief: Nanoform Sets Two New Near-Term Business Targets For 2022
Brief: Nanoform Q3 EBITDA Loss Widens To EUR 4.6 Mln
Brief: Nanoform Gets Certification For Its Information Security Management System
Brief: Nanoform Receives Funding To Solve Challenges For Global Health
Brief: Herantis Pharma Announces Successful Results With Nanoform Technology
Brief: Nanoform Q2 EBITDA Loss Narrows To EUR 4.4 Mln
Brief: Nanoform And Boehringer Ingelheim Execute Master Services Agreement
Brief: Nanoform Raises Its Mid-Term Business Targets For 2025
Brief: Nanoform Q1 EBITDA Loss Narrows To EUR 3.9 Million
Brief: Nanoform And Celanese Explore Ways To Enhance Drug Delivery
Brief: Nanoform: Final Clinical Results
Brief: Nanoform Finland Enters Collaboration With Aprecia
Brief: Nanoform, Nacuity Pharmaceuticals Sign Agreement For Ophthalmic Drug Candidates
Brief: Nanoform Finland Says Completed New Share Issue Raising EUR 40 Mln
Brief: Nanoform Finland PLC Announces Its Intention To Carry Out A New Share Issue To Raise Approximately EUR 40 Million
Brief: Nanoform Finland Q4 Operating Loss Widens To EUR 4.6 Mln
Brief: Nanoform Sets New Near-Term Business Target For 2021 And 2022